BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38641823)

  • 1. Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
    Zhang Y; Lei Y; Ou Q; Chen M; Tian S; Tang J; Li R; Liang Q; Chen Z; Wang C
    BMC Biol; 2024 Apr; 22(1):88. PubMed ID: 38641823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis.
    Zhang Y; Liu S; Chen M; Ou Q; Tian S; Tang J; He Z; Chen Z; Wang C
    BMC Cancer; 2024 Mar; 24(1):288. PubMed ID: 38439023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer.
    Jianyi D; Haili G; Bo Y; Meiqin Y; Baoyou H; Haoran H; Fang L; Qingliang Z; Lingfei H
    Cancer Immunol Immunother; 2023 Jan; 72(1):73-85. PubMed ID: 35725835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
    Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
    Front Immunol; 2020; 11():613215. PubMed ID: 33679700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6
    Jiang M; Chen J; Zhang W; Zhang R; Ye Y; Liu P; Yu W; Wei F; Ren X; Yu J
    Front Immunol; 2017; 8():1840. PubMed ID: 29326716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2/p-STAT3 signalling pathway.
    Li X; Wang J; Wu W; Gao H; Liu N; Zhan G; Li L; Han L; Guo X
    FEBS J; 2020 Dec; 287(23):5218-5235. PubMed ID: 32239647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer.
    Liang Y; Wang W; Zhu X; Yu M; Zhou C
    Sci Rep; 2022 Jun; 12(1):9619. PubMed ID: 35688951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host.
    Song G; Zhang Y; Tian J; Ma J; Yin K; Xu H; Wang S
    Front Immunol; 2021; 12():649020. PubMed ID: 33717204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMPRSS11D/ALR-mediated ER stress regulates the function of myeloid-derived suppressor cells in the cervical cancer microenvironment.
    Feng S; Zhao J; Yang T; Li L
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110869. PubMed ID: 37666068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.
    Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ
    Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
    Wang L; Hu D; Xie B; Xie L
    Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gansui-Banxia Decoction extraction inhibits MDSCs accumulation via AKT /STAT3/ERK signaling pathways to regulate antitumor immunity in C57bl/6 mice.
    Feng XY; Chen BC; Li JC; Li JM; Li HM; Chen XQ; Liu D; Li RT
    Phytomedicine; 2021 Dec; 93():153779. PubMed ID: 34638030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells.
    Xiao W; Klement JD; Lu C; Ibrahim ML; Liu K
    J Immunol; 2018 Jul; 201(1):264-277. PubMed ID: 29752314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.
    Ko HJ; Kim YJ
    Arch Pharm Res; 2016 Nov; 39(11):1597-1608. PubMed ID: 27572156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
    Zheng Y; Tian X; Wang T; Xia X; Cao F; Tian J; Xu P; Ma J; Xu H; Wang S
    Mol Cancer; 2019 Mar; 18(1):61. PubMed ID: 30925926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
    Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
    Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
    Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway.
    Yan D; Yang Q; Shi M; Zhong L; Wu C; Meng T; Yin H; Zhou J
    Eur J Immunol; 2013 Nov; 43(11):2943-55. PubMed ID: 23897117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.